Invivyd (IVVD) Assets (2020 - 2025)
Invivyd posted quarterly Assets of $276.9 million for Q4 2025, up 113.78% year-on-year from $129.5 million in Q4 2024, and up 98.97% on a QoQ basis from $139.2 million in Q3 2025.
Invivyd (IVVD) has 6 years of Assets data on file, last reported at $276.9 million in Q4 2025.
- For the quarter ending Q4 2025, Assets rose 113.78% year-over-year to $276.9 million; the trailing twelve-month figure through Dec 2025 stood at $276.9 million (up 113.78% YoY), and the FY2025 full-year result was $276.9 million, up 113.78% from the prior year.
- Assets for Q4 2025 stood at $276.9 million, up from $139.2 million in the prior quarter.
- Across five years, Assets topped out at $686.3 million in Q3 2021 and bottomed at $89.1 million in Q2 2025.
- The 5-year median for Assets is $276.9 million (2025), against an average of $316.7 million.
- The widest annual swing landed in 2021, when Assets jumped 428.27%; it then slumped 51.85% in 2025.
- A 5-year view of Assets shows it stood at $620.1 million in 2021, then plunged by 38.21% to $383.2 million in 2022, then tumbled by 40.19% to $229.2 million in 2023, then plunged by 43.49% to $129.5 million in 2024, then jumped by 113.78% to $276.9 million in 2025.
- The last three Assets figures came in at $276.9 million (Q4 2025), $139.2 million (Q3 2025), and $89.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | 276.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 276.88 Mn |
| Sep 30, 2025 | 139.16 Mn |
| Jun 30, 2025 | 89.14 Mn |
| Mar 31, 2025 | 103.74 Mn |
| Dec 31, 2024 | 129.52 Mn |
| Sep 30, 2024 | 161.92 Mn |
| Jun 30, 2024 | 177.35 Mn |
| Mar 31, 2024 | 215.47 Mn |
| Dec 31, 2023 | 229.18 Mn |
| Sep 30, 2023 | 274.92 Mn |
| Jun 30, 2023 | 315.41 Mn |
| Mar 31, 2023 | 350.56 Mn |
| Dec 31, 2022 | 383.17 Mn |
| Sep 30, 2022 | 424.75 Mn |
| Jun 30, 2022 | 484.61 Mn |
| Mar 31, 2022 | 556.27 Mn |
| Dec 31, 2021 | 620.09 Mn |
| Sep 30, 2021 | 686.27 Mn |
| Jun 30, 2021 | 397.99 Mn |
| Dec 31, 2020 | 117.38 Mn |